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The Brief Case
(For answers to the self-assessment questions and take-home points, see page 2628 in this issue [doi:10.1128/JCM.00050
-16].)

Dyspnea in a Profoundly Immunocompromised Man
Morgan A. Penceb

Department of Medicine, Division of Infectious Diseases,a and Department of Pathology & Immunology, Division of Laboratory and Genomic Medicine,b Washington
University School of Medicine, St. Louis, Missouri, USA

CASE

A

61-year-old male presented to a hospital in Missouri with
several months of progressive shortness of breath and lowgrade fevers. He had a past medical history of chronic obstructive
pulmonary disease and diffuse large B-cell lymphoma, which was
treated with a matched unrelated donor bone marrow transplant
10 months prior and was complicated by chronic graft-versushost disease, requiring significant immunosuppression with prednisone, tacrolimus, and mycophenolate mofetil. This was further
complicated by presumed Aspergillus species pneumonia (diagnosed by imaging and clinical syndrome). He was initially treated
with voriconazole and subsequently liposomal amphotericin B,
with gradual worsening. The patient lived in rural Missouri, where
he worked as a farmer; he denied any recent travel. Computed
tomography (CT) of the chest was performed and was concerning
for worsening fungal pneumonia (Fig. 1A). When a bronchoscopy
was performed to obtain a specimen, cottony white spots were
observed throughout the bronchial tree (Fig. 1B). The patient subsequently decompensated and required intubation. A direct Gram
stain of the tracheal aspirate collected immediately after intubation revealed the fruiting bodies of a fungus (Fig. 1C). Fungal
elements are uncommonly seen on direct Gram stains of clinical
specimens, and it is very rare to see fruiting bodies, as shown in
Fig. 1C. The tapering phialides with phialoconidia observed on
Gram staining resembled those of Penicillium or Paecilomyces species. The infectious diseases fellow taking care of the patient was
notified of the positive Gram stain and was provided a differential
diagnosis of Penicillium versus Paecilomyces species on the basis of
the Gram stain. Within 3 days of incubation, a yellow-tan mold
was recovered from both mycology cultures and aerobic bacteriology cultures (Fig. 1D). A lactophenol cotton blue scotch tape
prep revealed long, slender, tapering phialides characteristic of
Paecilomyces species. At the time of isolation, the standard of care
in the laboratory was to perform genus-level identification based
on morphology. On the basis of the macroscopic and microscopic
morphology, an identification of Paecilomyces sp. was reported.
Unfortunately, after the specimen was obtained, the patient continued to decompensate and expired shortly thereafter.
DISCUSSION

Paecilomyces species are emerging pathogens. Isolates were previously considered contaminants when recovered in culture because
of the ubiquitous nature of the genus, but because of the growing
number of immunocompromised patients, Paecilomyces is increasingly associated with disease (1). Paecilomyces species have
also been reported to cause infections in immunocompetent
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hosts, but this is much less common (1). Cases of endocarditis,
nephritis, pulmonary infections, and catheter-related fungemia, as
well as nail, ocular, cutaneous, and subcutaneous infections, have
been attributed to Paecilomyces species (2). Infection occurs through
inhalation, through breakdown of the skin, and through indwelling
catheters. Paecilomyces variotii and Paecilomyces lilacinus are the
two species most commonly associated with human infections.
Other species, such as Paecilomyces marquandii and Paecilomyces
javanicus, have also been reported, although less frequently (3). Of
note, P. lilacinus was recently reassigned to a novel genus, Purpureocillium, and renamed Purpureocillium lilacinum. However, it will
be included in the discussion below since it has historically been included in studies and reviews of Paecilomyces species.
Fungal pneumonia is a relatively common disease in bone
marrow transplant patients, especially during the profound
immunosuppression of graft-versus-host disease. The most
common causative agents are Aspergillus species, Fusarium species, members of the order Mucorales, and, less frequently, other
molds. Including this case, there have been five cases of Paecilomyces pneumonia reported to date (3). Of those, four patients
were immunocompromised, including two patients with hematologic malignancies, similar to the present case (3). Patient presentations consisted of fever, pleuritic pain, productive cough, and
dyspnea. Chest imaging demonstrated nodules, hilar lymphadenopathy, cavitary lesions, and opacities. Fungal structures
were seen on direct smear in three of the five cases, although in one
case, fungal structures were only noted on a second specimen
submitted 10 days after the initial smear-negative specimen. In the
other two cases, fungal forms were noted on histology of biopsy
and autopsy specimens, respectively. In the limited reported cases,
the mortality rate was 40% (3).
Paecilomyces species are members of the traditionally described
hyaline hyphomycetes and are found ubiquitously in the environment, primarily in soil, decaying plants, and food products. Paecilomyces species are known to feed on agricultural pests, leading
to their use as a bionematicide where the mold is liberally applied
on farms in order to provide enduring protection against pests.
Paecilomyces species have been used throughout the world and
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may have been used around the patient’s home town, where he
worked as a farmer. However, no human infection has ever been
conclusively associated with such practices.
Growth in culture is rapid; maturity is reached within 3 days.
Colonies are usually flat and powdery or velvety. The surface color
can be variable, ranging from yellow-tan, pink-mauve, and white
to yellow-green. Notably, P. lilacinum colonies are lilac in color
and typically grow more slowly than Paecilomyces species. However, the color of Paecilomyces colonies is never bright green or
blue-green, as seen with Penicillium species. The reverse is offwhite, pinkish, yellow, or pale brown (2). The difference in surface
color between the two genera is important for identification, as the
microscopic morphologies of Paecilomyces and Penicillium species
show a high degree of similarity. It is important to note that some
Penicillium species may not produce a characteristic blue-green
pigment and may resemble Paecilomyces species, potentially complicating correct identification.
The microscopic morphology of both genera, as demonstrated
by lactophenol cotton blue scotch tape prep, reveals septate hyphae with unbranched conidiophores. Flask-shaped phialides
with long, unbranched chains of round or oval single-celled phialoconidia are present. The major factors distinguishing the two
genera, in addition to colony color, are the length and shape of the
phialides. While the phialides of both genera are flask shaped, the
phialides of Paecilomyces species are more elongated and taper to a
long, slender neck, while the phialides of Penicillium species tend
to be shorter and more compact (2). Identification to the species
level on the basis of morphology alone is difficult.
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Because of the difficulty in identification to the species level on the
basis of morphology, molecular methods are more frequently being
used for the identification of Paecilomyces and related genera. In
one study, sequencing of internal transcribed spacer regions 1 and
2 and a portion of the beta-tubulin gene was performed for 34
isolates previously identified by morphological methods as P.
variotti or P. lilacinus (4). Of 31 isolates morphologically identified
as P. variotii, 5 (16%) were identified as either Talaromyces
eburneus or Hamigera avellanea by molecular methods.
Clinical management of Paecilomyces infection consists of antifungal therapy, surgery, or a combination of the two (5). Different species of Paecilomyces show various degrees of antifungal resistance. Of the two species most frequently isolated from human
infections, P. lilacinum is often highly resistant to amphotericin B
in vitro, while P. variottii is typically susceptible (5). In contrast, P.
variottii complex isolates appear to be resistant to voriconazole,
while P. lilacinum isolates are susceptible (4). Resistance to voriconazole has been reported both in vitro and in vivo (1, 6). This
includes a new diagnosis of voriconazole-resistant Paecilomyces
infection in a patient on voriconazole prophylaxis (6). While no
optimal antifungal treatment has been established, posaconazole
is emerging as an effective treatment for Paecilomyces because
there are no known cases of resistance (4, 5). Antifungal susceptibility testing of Paecilomyces species is not routinely performed in
clinical microbiology laboratories, and CLSI guidelines for performance or interpretation do not exist. In vitro susceptibility data
are available primarily from research studies. A recent in vitro
analysis found that posaconazole and terbinafine were the only
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FIG 1 (A) CT of the patient’s chest showing nodular infiltrates highly suggestive of fungal infection. (B) Bronchoscopy with a fungal growth (yellow arrow) on
the carina, next to the right main stem bronchus (blue arrow). (C) Direct Gram stain of patient’s tracheal aspirate showing tapering phialides with phialoconidia
suggestive of Penicillium or Paecilomyces species. (D) Yellow-tan colonies on Sabouraud dextrose agar characteristic of Paecilomyces species.
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SELF-ASSESSMENT QUESTIONS

1. Paecilomyces species may display various pigmentation;
however, isolates never appear:
(a) Yellow-tan
(b) Yellow-green
(c) Blue-green
(d) Pink-mauve
2. Paecilomyces species have not been associated with which of
the following infection(s):
(a) Endocarditis
(b) Catheter-related fungemia
(c) Skin infections
(d) Cholangitis
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3. Which antifungal is emerging as the most effective treatment for Paecilomyces species?
(a) Amphotericin B
(b) Posaconazole
(c) Voriconazole
(d) Flucytosine
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antifungals to achieve uniform in vitro susceptibility among all of
the clinical isolates tested (4). Because of the differences in in vitro
susceptibility profiles, accurate identification to the species level is
important to help guide appropriate therapy for severe infections,
although the correlation between in vitro and in vivo results remains to be elucidated.
In conclusion, pneumonia due to Paecilomyces species is rare
and is diagnosed primarily in immunocompromised hosts. However, despite the infrequency of Paecilomyces pneumonia, the
presence of molds other than Aspergillus and members of the order the Mucorales should be maintained in the differential diagnosis of fungal pneumonias in immunocompromised patients.
Early and aggressive microbiologic diagnosis should be sought in
cases without rapid improvement.

